Table 2.
Models | AUC (95% CI) | NRI(95% CI) | p value | IDI (95% CI) | p value |
---|---|---|---|---|---|
Outcome 1: Increase in/persistently high baPWV | |||||
Age + MAP | 0.73 (0.70–0.77) | – | – | – | – |
Age + MAP + LogTG | 0.74 (0.71–0.78) | 22.9% (7.8–37.9%) | 0.003 | 1.1% (0.4–1.9%) | 0.004 |
Age + MAP + LogTG/HDL-C | 0.74 (0.71–0.78) | 22.2% (7.0–37.4%) | 0.004 | 1.2% (0.4–2.0%) | 0.003 |
Outcome 2: Incident elevated baPWV | |||||
Age + MAP | 0.74 (0.69–0.79) | – | – | – | – |
Age + MAP + LogTG | 0.75 (0.70–0.81) | 40.7% (18.8–62.6%) | < 0.001 | 1.4% (0.1–2.6%) | 0.03 |
Age + MAP + LogTG/HDL-C | 0.75 (0.70–0.80) | 32.1% (10.1–54.1%) | 0.004 | 1.1% (0.0–2.2%) | 0.06 |
AUC area under the receiver operating curve, NRI net reclassification improvement, IDI integrated discrimination improvement, MAP mean arterial pressure, TG triglyceride, HDL-C high-density lipoprotein cholesterol